bioRxivNeurosciencePreprint
Heterogeneity of cognitive decline in dementia: a failed attempt to take into account variable time-zero severity
Steven John KiddleiD, Alice Carla Luisa ParodiiD, Caroline JohnstoniD, Chris WallaceiD, Richard DobsoniD, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative, and for the Coalition Against Major Diseases (CAMD)
Abstract
NOTEThe biases seen in simulations of Temporal Clustering appear to be even worse in real applications. While this was a novel and interesting approach, ultimately this work has been discontinued. I feel the biases are due to propagated error in estimating individual level offsets based on a single noisy measure, amplified by the fact that high MMSE scores change very slowly and therefore many estimates are from near an asymptote on the left hand of the model. We continue to work in this area, with other approaches showing significantly more promise.\n\nUnderstanding heterogeneity in Alzheimers disease (AD) progression is critically important for the optimal design of trials, allowing participants to be recruited who are correctly diagnosed and who are likely to undergo cognitive decline. Current knowledge about heterogeneity is limited by the paucity of long-term follow-up data and methodological challenges. Of the latter, a key problem is how to choose the most appropriate time zero to use in longitudinal models, a choice which affects results. Rather than a pre-specified time zero we propose a novel methodology - Temporal Clustering - that defines a new time zero using individual offsets inferred from the data. We applied this to longitudinal Mini-Mental State Examination (MMSE), where this approach ensures that individuals have similar estimated MMSE scores at this new time zero. Simulations showed that it could accurately predict cluster membership after the application of a filter. Next we applied it to a cohort of 2412 individuals, with large variability in MMSE score at first visit. Temporal Clustering was used to split individuals into two clusters. The group showing faster decline had higher average levels of AD risk factors: cerebrospinal fluid tau and APOE [isin]4. Cluster membership predicted by Temporal Clustering was less affected by individuals cognitive ability at first visit than was the case for clusters found using Latent Class Mixture Models. Further application and development of this method will help researchers to identify risk factors affecting cognitive decline.
- organism: human
- assay: bulk RNA-seq
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Examining heterogeneity in dementia using data-driven unsupervised clustering of cognitive profiles
Sayantan Kumar, Inez Y. Oh, … Philip Payne·PLoS ONEPeer-reviewed·Nov 14, 2024
- Fully Bayesian longitudinal unsupervised learning for the assessment and visualization of AD heterogeneity and progression
Konstantinos Poulakis, Daniel Ferreira, … Eric Westman·AgingPeer-reviewed·Jul 9, 2020
- Amyloid duration is associated with preclinical cognitive decline and tau PET
Rebecca L. Koscik, Tobey J. Betthauser, … Sterling C. Johnson·Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringPeer-reviewed·Jan 1, 2020
- Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer’s disease
Xiuming Zhang, Elizabeth Mormino, … Alzheimer's Disease Neuroimaging Initiative·bioRxiv·Jul 17, 2016
- Optimizing Cognitive Phenotyping for Genetic Discovery in Alzheimer's Disease: A Simulation-Based Evaluation of Mini-Mental State Examination-Based Decline Measures
Ruyu Shi, Eleanor Feingold, … Kang-Hsien Fan·bioRxiv·Oct 22, 2026
- Cognitive Changes associated with Alzheimer’s disease in Down syndrome
Nicholas C. Firth, Carla Marie Startin, … André Strydom·bioRxiv·Feb 21, 2018